Hedge Fund - Perceptive Advisors
Neurocrine Biosciences Inc (NBIX)
Holding History Records
No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
---|---|---|---|---|---|
1 | 2025 - Q1 (2025-03-31) | $11,065,530 | 0.39% | 100,050 | $126.68 |
2 | 2024 - Q4 (2024-12-31) | $13,656,825 | 0.37% | 100,050 | $123.68 |
3 | 2024 - Q3 (2024-09-30) | $24,452,910 | 0.51% | 212,228 | $137.09 |
4 | 2024 - Q2 (2024-06-30) | $89,472,972 | 2.15% | 649,909 | $137.14 |
5 | 2024 - Q1 (2024-03-31) | $110,944,089 | 1.94% | 804,409 | $136.57 |
6 | 2023 - Q4 (2023-12-31) | $35,679,817 | 0.79% | 270,794 | $115.11 |
7 | 2023 - Q3 (2023-09-30) | $17,914,725 | 0.59% | 159,242 | $105.30 |
8 | 2023 - Q2 (2023-06-30) | $9,434,715 | 0.27% | 100,050 | $97.71 |
9 | 2023 - Q1 (2023-03-31) | $10,127,061 | 0.29% | 100,050 | $104.06 |
10 | 2022 - Q4 (2022-12-31) | $11,949,972 | 0.33% | 100,050 | $117.13 |
11 | 2022 - Q3 (2022-09-30) | $10,626,000 | 0.3% | 100,050 | $101.46 |
12 | 2022 - Q2 (2022-06-30) | $38,786,000 | 1.21% | 397,888 | $92.29 |
13 | 2022 - Q1 (2022-03-31) | $37,091,000 | 0.74% | 395,639 | $84.75 |
14 | 2021 - Q4 (2021-12-31) | $41,138,000 | 0.63% | 483,007 | $91.99 |
15 | 2021 - Q3 (2021-09-30) | $46,325,000 | 0.67% | 483,007 | $94.46 |
16 | 2021 - Q2 (2021-06-30) | $79,007,000 | 1.02% | 811,832 | $95.85 |
17 | 2021 - Q1 (2021-03-31) | $91,593,000 | 1.15% | 941,832 | $104.86 |
18 | 2020 - Q4 (2020-12-31) | $182,040,000 | 1.95% | 1,899,215 | $96.59 |
19 | 2020 - Q3 (2020-09-30) | $148,924,000 | 2.17% | 1,548,715 | $115.68 |
20 | 2020 - Q2 (2020-06-30) | $261,252,000 | 4.23% | 2,141,410 | $110.51 |
21 | 2020 - Q1 (2020-03-31) | $265,126,000 | 6.9% | 3,063,263 | $97.87 |
22 | 2019 - Q4 (2019-12-31) | $388,313,000 | 7.71% | 3,612,554 | $104.70 |
23 | 2019 - Q3 (2019-09-30) | $365,837,000 | 9.85% | 4,059,900 | $93.43 |
24 | 2019 - Q2 (2019-06-30) | $339,734,000 | 7.79% | 4,023,862 | $82.11 |
25 | 2019 - Q1 (2019-03-31) | $331,138,000 | 9.34% | 3,758,662 | $83.58 |
26 | 2018 - Q4 (2018-12-31) | $315,363,000 | 12% | 4,608,554 | $95.81 |
27 | 2018 - Q3 (2018-09-30) | $587,363,000 | 15.7% | 4,777,254 | $113.46 |
28 | 2018 - Q2 (2018-06-30) | $463,226,000 | 12.14% | 4,715,250 | $89.51 |
29 | 2018 - Q1 (2018-03-31) | $394,912,000 | 11.06% | 4,761,989 | $84.45 |
30 | 2017 - Q4 (2017-12-31) | $399,712,000 | 13.24% | 5,151,589 | $68.21 |
31 | 2017 - Q3 (2017-09-30) | $293,629,000 | 11.21% | 4,791,589 | $52.77 |
32 | 2017 - Q2 (2017-06-30) | $164,569,000 | 8.28% | 3,577,589 | $48.51 |
33 | 2017 - Q1 (2017-03-31) | $145,771,000 | 8.3% | 3,366,530 | $42.84 |
34 | 2016 - Q4 (2016-12-31) | $128,349,000 | 9.12% | 3,316,523 | $45.27 |
35 | 2016 - Q3 (2016-09-30) | $125,398,000 | 8.09% | 2,476,272 | $49.80 |
36 | 2016 - Q2 (2016-06-30) | $127,167,000 | 8.81% | 2,797,967 | $46.04 |
37 | 2016 - Q1 (2016-03-31) | $107,614,000 | 9.43% | 2,720,967 | $39.68 |
38 | 2015 - Q4 (2015-12-31) | $141,208,000 | 10.44% | 2,496,167 | $50.83 |
39 | 2015 - Q3 (2015-09-30) | $117,101,000 | 9.36% | 2,942,967 | $48.33 |
40 | 2015 - Q2 (2015-06-30) | $156,866,000 | 9.44% | 3,284,467 | $42.40 |
41 | 2015 - Q1 (2015-03-31) | $148,566,000 | 11.54% | 3,741,267 | $35.77 |
42 | 2014 - Q4 (2014-12-31) | $79,648,000 | 6.67% | 3,565,267 | $18.95 |
43 | 2014 - Q3 (2014-09-30) | $71,538,000 | 7.75% | 4,565,267 | $14.95 |
44 | 2014 - Q2 (2014-06-30) | $68,262,000 | 6.69% | 4,599,867 | $14.11 |
45 | 2014 - Q1 (2014-03-31) | $74,372,000 | 7.81% | 4,619,367 | $17.10 |
46 | 2013 - Q4 (2013-12-31) | $39,076,000 | 4.69% | 4,183,737 | $9.76 |
47 | 2013 - Q3 (2013-09-30) | $48,344,000 | 3.92% | 4,270,704 | $13.75 |
48 | 2013 - Q2 (2013-06-30) | $67,993,000 | 6.85% | 5,081,717 | $12.28 |
49 | 2013 - Q1 (2013-03-31) | $53,492,000 | 6.42% | 4,402,637 | $10.18 |
50 | 2012 - Q4 (2012-12-31) | $30,609,000 | 5.41% | 4,092,137 | $7.60 |
51 | 2012 - Q3 (2012-09-30) | $29,296,000 | 6.67% | 3,671,137 | $7.64 |
52 | 2012 - Q1 (2012-03-31) | $28,724,000 | 6.87% | 3,604,037 | $8.47 |
The displayed share prices are average quarterly stock market prices.